Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 6209-6215, November 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jähde, E.
Right arrow Articles by Rajewsky, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jähde, E.
Right arrow Articles by Rajewsky, M. F.

pH in Human Tumor Xenografts and Transplanted Rat Tumors: Effect of Insulin, Inorganic Phosphate, and m-Iodobenzylguanidine1

Eckhard Jähde, Thomas Volk, Anita Atema, Lou A. Smets, Karl-Heinz Glüsenkamp and Manfred F. Rajewsky2

Institute of Cell Biology (Cancer Research), West German Cancer Center Essen, University of Essen Medical School, Hufelandstrasse 55, D-4300 Essen 1, Germany [E. J., T. V., K-H. G., M. F. R.], and Division of Experimental Therapy, the Netherlands Cancer Institute, Plesmanlaan 121, NL-1066 CX Amsterdam, the Netherlands [A. A., L. A. S.]

Various strategies to improve the therapeutic index of anticancer agents aim at inducing, by stimulation of aerobic glycolysis, temporary pH differences between malignant and normal tissues which can be exploited to activate cytotoxic agents selectively in tumors. We have investigated whether the pH reduction induced by glucose, the "drug" commonly used to increase lactic acid production in malignant tissues, can be augmented by pharmacological manipulation of tumor cell glycolysis. At normal plasma glucose concentration (6 ± 1 mM), inorganic phosphate, a modifier of hexokinase and phosphofructokinase activity, had no effect on pH in two transplanted rat tumors and a human tumor xenograft line (average pH, 6.80; range, 6.65–6.95). When plasma glucose concentration was raised to 30 ± 3 mM by i.v. infusion of glucose, inorganic phosphate reduced the pH in those tumors which exhibited only a moderate pH response to glucose per se (mean pH, 6.60) to an average value of 6.20 (range, 6.05–6.35). In the same setting, insulin, continuously infused at dose rates up to 600 milliunits/kg body weight/min, did not result in acidification of tumor tissue exceeding that induced by glucose alone. However, the H+ ion activity in both transplanted rat tumors and human tumor xenografts was increased by m-iodobenzylguanidine (MIBG), an inhibitor of mitochondrial respiration. For example, at normoglycemia, MIBG reduced the mean pH in a human mesothelioma xenograft from 6.90 to 6.70. This pH value was further reduced to 6.20 by simultaneous low-dose i.v. glucose infusion (plasma glucose concentration, 14 ± 3 mM). The acidosis induced by inorganic phosphate and MIBG was tumor specific. Normal tissues of tumor-bearing hosts were only marginally sensitive to hyperphosphatemia or MIBG administration. These results indicate that the known stimulatory effect of exogenous glucose on lactic acid production in malignant tumors in vivo can be further accentuated or, as in the case of MIBG, partially replaced by pharmacological manipulation of aerobic glycolysis using clinically established drugs.

1 Supported by Dr. Mildred Scheel Stiftung für Krebsforschung (Grant W 15/88 Ra 3) and the Dutch Cancer Foundation (Contract NK1-91-14).

2 To whom requests for reprints should be addressed.

Received 4/27/92. Accepted 9/11/92.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
L. E. Gerweck, S. Vijayappa, and S. Kozin
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
Mol. Cancer Ther., May 1, 2006; 5(5): 1275 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Zhou, N. Bansal, D. B. Leeper, and J. D. Glickson
Intracellular Acidification of Human Melanoma Xenografts by the Respiratory Inhibitor m-Iodobenzylguanidine Plus Hyperglycemia: A 31P Magnetic Resonance Spectroscopy Study
Cancer Res., July 1, 2000; 60(13): 3532 - 3536.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
D. M. Prescott, H. C. Charles, J. M. Poulson, R. L. Page, D. E. Thrall, Z. Vujaskovic, and M. W. Dewhirst
The Relationship between Intracellular and Extracellular pH in Spontaneous Canine Tumors
Clin. Cancer Res., June 1, 2000; 6(6): 2501 - 2505.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.